Bextra (generic name: valdecoxib) is a drug prescribed for osteoarthritis, adult rheumatoid arthritis, and for serious menstrual cramps.
Click Here for Bextra Resources
Bextra falls within a sub-category of NSAIDs (non-steroidal anti-inflammatory drugs) known as a Cox-2 inhibitors, which block the COX-2 enzyme that causes most arthritis pain and inflammation.
Phamacia and Pfizer are the manufacturers and marketers of Bextra. They are among the largest drug companies in the world. It is estimated that approximately one million people have taken Bextra.
The timeline of the Bextra drug controversy is well documented in an article published on WebMD entitled: Timeline of Pain Reliever Controversy, Tracing the Path on Cox-2, NSAID Pain Relievers by Mirandi Hitti. Prior to Bextra's recall in April of 2005, the FDA had the drug's manufacturers strengthen their warnings about adverse reactions in November of 2002. In January of 2005, the FDA sent a letter to the makers of Bextra regarding misrepresentations in various advertisements and commercials about the drug. Read a copy here.
On April 7, 2005, Bextra was removed from the market by the FDA because it provided no advantage over other painkillers and posed life-threatening health risks, including Stevens-Johnson Syndrome.
However, this recall does not help the millions of people who took Bextra, nor the untold number of patients and their families who were harmed by the drug before it was taken off the market. Many of the side effects of adverse reactions to Bextra, such as those from Stevens-Johnson Syndrome have permanent and serious life-altering consequences such as blindness and other disabilities, and many patients died as a result of their use of this supposedly safe drug.
Stevens-Johnson Syndrome is an exfoliative skin disease affecting the skin and mucous membranes with painful, blistering and life threatening lesions. The prognosis and lasting effects of Stevens-Johnson Syndrom vary significantly depending on the individual, the form of the disease, and the extent of involvement of skin and musosa. The more severe forms of the disease can result in disfiguring scarring, impairment or loss of vision, and secondary infections including systemic sepsis. In the case of the TEN form of Stevens-Johnson Syndrome, death results in about one-third of cases. The disease can have life altering consequences for those who survive it, and many do not survive.
If you or a loved one has been afflicted with Stevens-Johnson Syndrome, please e-mail or call us today and we will evaluate your Stevens-Johnson claim for free.
The law firm of Levin, Papantonio, Thomas, Mitchell, Echsner & Proctor, P.A. is nationally recognized as the fourth-winningest law firm in the United States. Our attorneys specialize in product liability and drug litigation cases.